[logo] HealthTree Foundation
more_vert
close
person Sign In / Create Account

When It's Too Late to Join a Clinical Trial and the New Drug Selinexor with Dr. Nikoletta Lendvai, MD, PhD, MKSCC

When It's Too Late to Join a Clinical Trial and the New Drug Selinexor with Dr. Nikoletta Lendvai, MD, PhD, MKSCC image

When It's Too Late to Join a Clinical Trial and the New Drug Selinexor with Dr. Nikoletta Lendvai, MD, PhD, MKSCC

Podcast
event Oct 28, 2016 / 11:00AM MDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Nikoletta Lendvai, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: October 28, 2016 

 Why should patients participate in clinical trials and is it ever too late to join one? Dr. Lendvai tells us that every stage is a good time to consider clinical trials, but when you've run out of options isn't one of them. She shares insight into the details of joining clinical trials (like who pays) and discusses the new drug in clinical trial - selinexor - as an example. This drugs is now being used to help patients who have become refractory to proteasome inhibitors like Velcade and iMiDs like Revlimid. In early studies, it looks like this drug can make many patients sensitive again to these prior treatment options. Dr. Lendvai shares clinical trials open at MSKCC for newly diagnosed patients, smoldering myeloma patients, clinical trials for transplants and for relapsed/refractory patients. It is very clear that going to an academic myeloma center gives patients a large number of options to take advantage of newer treatments that have not yet been approved.

multiple myeloma

Thanks to our episode sponsor

Schedule & Agenda

Event panelist Dr. Nikoletta Lendvai & Jenny Ahlstrom
11:00 AM
Discussion
Dr. Nikoletta Lendvai & Jenny Ahlstrom

Speakers & Moderators

The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

Thanks to our sponsors:
Johnson and Johnson logo
Sanofi logo
Pfizer logo
GSK logo
Regeneron logo
All HealthTree resources available anywhere, anytime
Download our App
Download iOS App Download Android App
iphone app mockup
newsletter icon

Get the Latest Multiple Myeloma Updates, Delivered to You.

By subscribing to the HealthTree newsletter, you'll receive the latest research, treatment updates, and expert insights to help you navigate your health.